Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
gene editing
5
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
vc
5
×
biotech
boulder/denver blog main
boulder/denver top stories
celgene
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
crispr
ipo
scott gottlieb
abbvie
amgen
apremilast
biogen
cancer
car-t
What
bio
5
×
roundup
crispr
gene
years
abbvie’s
allogene
barbecuing
becker
billions
biopharma
camping
cancer
car
cardiologist
celgene
center
check
cholesterol
colleagues
conference
create
day
diagnostic
diseases
diversity
dollars
eaton
editing
exome
fix
flop
government
health
healthcare
heats
high
hit
hot
human
Language
unset
Current search:
vc
×
bio
×
" gene editing "
×
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More